Patent details

EP3432871 Title: TREATMENT OF UREMIC PRURITUS

Basic Information

Publication number:
EP3432871
PCT Application Number:
US2017023398
Type:
European Patent Granted for LU
Legal Status:
Lapsed
Application number:
EP177709813
PCT Publication Number:
WO2017165409
First applicant's nationality:
Translation Language:
EPO Publication Language:
English
English Title of Invention:
TREATMENT OF UREMIC PRURITUS
French Title of Invention:
TRAITEMENT DU PRURIT URÉMIQUE
German Title of Invention:
BEHANDLUNG VON URÄMISCHEM PRURITUS
SPC Number:

Dates

Filing date:
21/03/2017
Grant date:
15/11/2023
EP Publication Date:
30/01/2019
PCT Publication Date:
28/09/2017
Claims Translation Received Date:
Translations Received Date (B1 EP Publication):
Translations Received Date (B2 EP Publication):
Translations Received Date (B3 EP Publication):
Publication date:
15/11/2023
EP B1 Publication Date:
15/11/2023
EP B2 Publication Date:
EP B3 Publication Date:
Lapsed date:
21/03/2024
Expiration date:
21/03/2037
Renunciation date:
Revocation date:
Annulment date:

Owner

From:
08/11/2023
 
 

Name:
Trevi Therapeutics, Inc.
Address:
195 Church Street 14th Floor, New Haven, Connecticut 06510, United States (US)

Inventor

1

Name:
SCIASCIA, Thomas
Address:
United States (US)

2

Name:
GOOD, Jennifer
Address:
United States (US)

3

Name:
HAWI, Amale
Address:
United States (US)

Priority

1

Priority Number:
201662311134 P
Priority Date:
21/03/2016
Priority Country:
United States (US)

2

Priority Number:
201662412584 P
Priority Date:
25/10/2016
Priority Country:
United States (US)

Classification

IPC classification:
A61K 31/192; A61K 31/485; A61K 9/20; A61K 45/06; A61P 17/04;

Publication

European Patent Bulletin

Issue number:
202346
Publication date:
15/11/2023
Description:
Grant (B1)

Annual Fees

Annual Fee Due Date:
Annual Fee Number:
Expected Payer:
Last Annual Fee Payment Date:
Last Annual Fee Paid Number:
Payer:
Filing date Document type Number of pages